Skip to main content
Clinical Trials/NCT03700541
NCT03700541CompletedPhase 4

Influence of Peri-operative Opioid Analgesia on Circulating Tumor Cells in Patients Undergoing Laparoscopic Colorectal Cancer Surgery - Multi-center, Randomized Clinical Trial

The Institute of Molecular and Translational Medicine, Czech Republic3 sites in 1 country71 target enrollmentStarted: January 7, 2019Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
71
Locations
3
Primary Endpoint
Change in number of circulating tumor cells prior to surgery to 2 - 4 weeks after surgery

Study Overview

Brief Summary

To compare the effects of three types of perioperative analgesia on the number of circulating tumor cells following radical colorectal cancer surgery. To find correlations with other perioperative factors and clinical/pathological disease characteristics.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • patients undergoing open radical surgery for colorectal cancer
  • age over 18 years
  • signed informed consent

Exclusion Criteria

  • intolerance of the study drugs
  • history of CRC surgery
  • neoadjuvant therapy
  • other malignancy not in permanent remission
  • chronic opioid medication or opioid administration within 7 days preoperatively
  • immunosuppressive or corticosteroid therapy
  • surgery within 30 days preoperatively (except minor)
  • chronic or acute infection

Arms & Interventions

Morphine

Active Comparator

Morphine-based perioperative analgesia

Intervention: Morphine (Drug)

Piritramid

Active Comparator

Piritramid-based perioperative analgesia

Intervention: Piritramid (Drug)

Outcomes

Primary Outcomes

Change in number of circulating tumor cells prior to surgery to 2 - 4 weeks after surgery

Time Frame: 1 - 3 days before surgery to 4 weeks after surgery

Baseline number of circulating tumor cells will be recorded prior to surgery in a venous blood sample. Number of circulating tumor cells will be measured 2 - 4 weeks after surgery in a venous blood sample. These two values will be compared.

Secondary Outcomes

  • Pain assessment(Time Frame: 3 days postoperatively)

Investigators

Sponsor
The Institute of Molecular and Translational Medicine, Czech Republic
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (3)

Loading locations...

Similar Trials